» Articles » PMID: 1657150

Human Substance P Receptor (NK-1): Organization of the Gene, Chromosome Localization, and Functional Expression of CDNA Clones

Overview
Journal Biochemistry
Specialty Biochemistry
Date 1991 Nov 15
PMID 1657150
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

The gene for the human substance P receptor (NK-1) was cloned using cDNA probes made by the polymerase chain reaction from primers based on the rat sequence. The gene spans 45-60 kb and is contained in five exons, with introns interrupting at sites homologous to those in the NK-2 receptor gene. Analysis of restriction digests of genomic DNA from mouse/human cell hybrids indicates the NK-1 receptor is a single-copy gene located on human chromosome 2. Polymerase chain reaction using primers based on the 5' and 3' ends of the coding sequence was used to generate full-length cDNAs from human lung and from IM9 lymphoblast cells. When transfected into COS-7 cells, the NK-1 receptor binds 125I-BHSP with a Kd of 0.35 +/- 0.07 nM and mediates substance P induced phosphatidylinositol metabolism. The receptor is selective for substance P; the relative affinity for neurokinin A and neurokinin B is 100- and 500-fold lower, respectively. Human IM9 lymphoblast cells express relatively high levels of the NK-1 receptor, and Northern blot analysis indicates modulation of mRNA levels by glucocorticoids and growth factors, suggesting that this cell line may be useful as a model for studying the control of NK-1 receptor gene expression.

Citing Articles

Comparison between Substance P and Calcitonin Gene-Related Peptide and Their Receptors in Colorectal Adenocarcinoma.

Serban R, Boldeanu M, Florescu D, Ionescu M, Serbanescu M, Boldeanu L J Clin Med. 2024; 13(18).

PMID: 39337103 PMC: 11432560. DOI: 10.3390/jcm13185616.


The use of SP/Neurokinin-1 as a Therapeutic Target in Colon and Rectal Cancer.

Martin-Garcia D, Tellez T, Redondo M, Garcia-Aranda M Curr Med Chem. 2023; 31(39):6487-6509.

PMID: 37861026 DOI: 10.2174/0109298673261625230924114406.


The effect of substance P and its common in vivo-formed metabolites on MRGPRX2 and human mast cell activation.

Hsin L, Fernandopulle N, Ding J, Lumb C, Veldhuis N, Karas J Pharmacol Res Perspect. 2022; 10(4):e00990.

PMID: 35904495 PMC: 9337217. DOI: 10.1002/prp2.990.


Neurokinin-1 Receptor (NK-1R) Antagonists as a New Strategy to Overcome Cancer Resistance.

Garcia-Aranda M, Tellez T, McKenna L, Redondo M Cancers (Basel). 2022; 14(9).

PMID: 35565383 PMC: 9102068. DOI: 10.3390/cancers14092255.


New Insights on Metabolic and Genetic Basis of Migraine: Novel Impact on Management and Therapeutical Approach.

Simonetta I, Riolo R, Todaro F, Tuttolomondo A Int J Mol Sci. 2022; 23(6).

PMID: 35328439 PMC: 8955051. DOI: 10.3390/ijms23063018.